Title |
The Emerging Role of Targeted Therapy and Immunotherapy in the Management of Brain Metastases in Non-Small Cell Lung Cancer
|
---|---|
Published in |
Frontiers in oncology, April 2017
|
DOI | 10.3389/fonc.2017.00033 |
Pubmed ID | |
Authors |
Annick Wong |
Abstract |
Lung cancer is the worldwide leading cause of cancer-related mortality in men and second leading in women. Brain metastases (BM) account for 10% of non-small cell lung cancer (NSCLC) patients at initial presentation, with another 25-40% developing BM during the course of their disease. In the last decade, the field of precision oncology has led to the discovery of a multitude of heterogenous molecular abnormalities within NSCLC as well as the development of tyrosine kinase inhibitors that target them. In this review, the focus will be on targeted therapy and immunotherapy that show efficacy in BM rather than conventional treatment for multiple BM (such as surgical resection, WBRT, or stereotactic radiosurgery). |
X Demographics
As of 1 July 2024, you may notice a temporary increase in the numbers of X profiles with Unknown location. Click here to learn more.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 52 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 7 | 13% |
Student > Bachelor | 5 | 10% |
Student > Doctoral Student | 5 | 10% |
Student > Postgraduate | 4 | 8% |
Student > Master | 4 | 8% |
Other | 8 | 15% |
Unknown | 19 | 37% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 16 | 31% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 8% |
Biochemistry, Genetics and Molecular Biology | 2 | 4% |
Nursing and Health Professions | 2 | 4% |
Agricultural and Biological Sciences | 2 | 4% |
Other | 5 | 10% |
Unknown | 21 | 40% |